CanadaBis Capital Inc. CANBH.V

Company Overview

CanadaBis Capital Inc. is a Canadian cannabis company focused on the production, processing, branding, and distribution of recreational cannabis products. The company has operated primarily through its subsidiary Stigma Grow, which has been associated with cannabis cultivation, hydrocarbon extraction, and the commercialization of branded cannabis products in the Canadian adult-use market. Public disclosures and market coverage indicate that the company’s operations have centered on cannabis flower, concentrates, pre-rolls, and derivative products sold through provincial distribution systems and licensed retail channels.

The company has historically positioned itself within the higher-potency and concentrate segments of the Canadian cannabis market, emphasizing extraction capabilities and branded consumer products. CanadaBis Capital evolved during the broader expansion of Canada’s legalized cannabis industry following federal legalization in 2018. Available public filings and market disclosures indicate that the company pursued vertical integration through cultivation, extraction, manufacturing, and brand development activities. Some historical operational details vary across public disclosures, and certain current operational metrics are inconclusive based on available public sources.

Business Operations

CanadaBis Capital’s operations have historically been concentrated within the Canadian recreational cannabis sector through Stigma Grow and related cannabis-processing activities. The company’s revenue generation has been tied to wholesale cannabis distribution, branded product sales, extraction services, and cannabis derivative manufacturing. Publicly available information indicates that the company operated licensed cultivation and processing facilities in Alberta, with products distributed into multiple provincial markets across Canada.

The company’s operational model emphasized extraction technologies and hydrocarbon processing capabilities used in cannabis concentrates and vape-related products. CanadaBis Capital also maintained exposure to branded cannabis consumer products through offerings associated with the Stigma Grow and Dab Bods brands. Available filings and industry reports suggest partnerships with provincial distributors and licensed retailers rather than large-scale international operations. Public information regarding major joint ventures or significant foreign subsidiaries remains limited, and some partnership details are inconclusive based on available public sources.

Strategic Position & Investments

CanadaBis Capital’s strategic direction has historically focused on expanding higher-margin cannabis derivative products, particularly concentrates and branded recreational products. The company pursued growth through the development of in-house extraction capabilities and brand positioning within premium and high-potency product categories. Industry reporting and company disclosures indicate that management viewed cannabis concentrates and derivative products as differentiated growth opportunities within the Canadian legal cannabis market.

The company’s most notable operating asset has been Stigma Grow, which functioned as a central platform for cultivation, extraction, and manufacturing activities. CanadaBis Capital also pursued product portfolio expansion through concentrate and vape-related offerings under brands such as Dab Bods. Publicly available records do not indicate major international acquisitions or diversified non-cannabis investments on the scale of larger cannabis operators. Information regarding recent capital deployment strategies, material acquisitions, or emerging technology investments is limited and, in some areas, inconclusive based on available public sources.

Geographic Footprint

CanadaBis Capital’s operational footprint has primarily been concentrated in Canada, with core activities centered in Alberta. The company’s cultivation, processing, and manufacturing operations have historically been tied to licensed Canadian cannabis facilities serving the domestic adult-use market. Distribution exposure extended into multiple Canadian provinces through regulated provincial cannabis distribution systems.

There is limited evidence in public filings and market disclosures of significant direct international operations or overseas production assets. The company’s market presence appears to have remained primarily domestic rather than multinational. While Canadian cannabis companies have broadly explored export opportunities, publicly verifiable information confirming material international operational influence by CanadaBis Capital is inconclusive based on available public sources.

Leadership & Governance

CanadaBis Capital has historically been governed through a management team with experience in cannabis operations, extraction, and public-company administration. Public disclosures indicate that leadership strategy emphasized operational efficiency, cannabis product differentiation, and the expansion of branded derivative products within Canada’s regulated cannabis market. However, executive composition has changed over time, and some current leadership details are not consistently reflected across recent public sources.

Key executives and directors identified in historical public disclosures include:

• Scott Dyer – Chief Executive Officer
• Travis McIntyre – Chief Operating Officer
• Steve Laviolette – Director and cannabis industry executive

Certain executive appointments, board memberships, and current governance structures may have changed subsequent to earlier public filings. Some leadership information is inconclusive based on available public sources.